{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03671889",
            "orgStudyIdInfo": {
                "id": "AL002"
            },
            "organization": {
                "fullName": "InSightec",
                "class": "INDUSTRY"
            },
            "briefTitle": "ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease",
            "officialTitle": "Assessment of Safety and Efficacy of ExAblate Blood-Brain Barrier Disruption for the Treatment of Patients With Probable Alzheimer's Disease",
            "therapeuticArea": [
                "Neurology"
            ],
            "study": "exablate-blood-brain-barrier-bbb-disruption-for-the-treatment-of-alzheimer-s-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2018-09-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2018-08-03",
            "studyFirstSubmitQcDate": "2018-09-12",
            "studyFirstPostDateStruct": {
                "date": "2018-09-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-04",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "InSightec",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).",
            "detailedDescription": "This is a prospective, multi-center, single-arm study to evaluate the safety and efficacy of BBB disruption using the ExAblate Model 4000 Type 2.0 (220 kHz) system. Patients with diagnosis of Probable Alzheimer's Disease may qualify for a clinical trial to have three serial ExAblate BBB disruption procedures in specific areas in the brain. This study will be conducted at up to 8 sites in the United States and will enroll up to 30 patients."
        },
        "conditionsModule": {
            "conditions": [
                "Alzheimer Disease"
            ],
            "keywords": [
                "Alzheimer Disease",
                "Alzheimer Syndrome",
                "Magnetic Resonance guided Focal Ultrasound (MRgFUS)",
                "Blood-Brain Barrier",
                "ExAblate"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "Subjects who meet study eligibility will undergo treatment procedures in groups by staged volumes.",
                "primaryPurpose": "DEVICE_FEASIBILITY",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 150,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Blood Brain Barrier (BBB) Disruption",
                    "type": "EXPERIMENTAL",
                    "description": "ExAblate Model 4000 Type 2.0 System",
                    "interventionNames": [
                        "Device: Blood Brain Barrier (BBB) Disruption"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Blood Brain Barrier (BBB) Disruption",
                    "description": "Focal Ultrasound (FUS) involves the application of acoustic energy at low frequencies from over 1000 individual transducers into distinct targets to induce BBB disruption.",
                    "armGroupLabels": [
                        "Blood Brain Barrier (BBB) Disruption"
                    ],
                    "otherNames": [
                        "ExAblate Neuro"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Device and procedure related adverse events",
                    "description": "Rate of adverse events following each treatment through end of study",
                    "timeFrame": "5 years"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "BBB Disruption and Closure",
                    "description": "MR images post-procedure to verify that the BBB was disrupted and subsequently closed within 24 hours.",
                    "timeFrame": "Immediately after the end of each ExAblate treatment and 24 hours post treatment"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Male or Female between 50-85 years of age\n2. Probable Alzheimer's Disease (AD)\n3. If taking concurrent Alzheimer's medication, has been on the medication for at least 2 months with a stable dose for at least 3 months\n4. Able to communicate sensations during the ExAblate MRgFUS procedure\n5. Ambulatory\n\nExclusion Criteria:\n\n1. MRI Findings\n2. Presence of unknown or MR unsafe devices anywhere in the body\n3. Significant cardiac disease or unstable hemodynamic status\n4. Relative contraindications to ultrasound contrast agent or PET amyloid tracer\n5. History of a bleeding disorder\n6. History of liver disease\n7. Known cerebral or systemic vasculopathy\n8. Significant depression and at potential risk of suicide\n9. Any contraindications to MRI scanning\n10. Any contraindication to lumbar puncture for collection of cerebral spinal fluid\n11. Untreated, uncontrolled sleep apnea\n12. History of seizure disorder or epilepsy\n13. Severely Impaired renal function\n14. Currently in a clinical trial involving an investigational product or non-approved use of a drug or device or in any other type of medical research\n15. Chronic pulmonary disorders\n16. Positive human immunodeficiency virus (HIV)\n17. Known apolipoprotein E allele (ApoE4) homozygosity",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "50 Years",
            "maximumAge": "85 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "locations": [
                {
                    "facility": "Delray Medical Center & Florida Atlantic University",
                    "status": "RECRUITING",
                    "city": "Delray Beach",
                    "state": "Florida",
                    "zip": "33484",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jenny Zucker, MS",
                            "role": "CONTACT",
                            "phone": "561-825-1505",
                            "email": "JennyZucker712@gmail.com"
                        },
                        {
                            "name": "Lloyd Zucker, MD, FAANS",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.46146,
                        "lon": -80.07282
                    }
                },
                {
                    "facility": "Broward Health Medical Center & The University of Florida",
                    "status": "RECRUITING",
                    "city": "Fort Lauderdale",
                    "state": "Florida",
                    "zip": "33316",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joan Osborne, EdD",
                            "role": "CONTACT",
                            "phone": "954-355-5563",
                            "email": "BHResearch@browardhealth.org"
                        },
                        {
                            "name": "Celena Bodie",
                            "role": "CONTACT",
                            "phone": "654-786-6736",
                            "email": "Cbodie@browardhealth.org/"
                        },
                        {
                            "name": "Shaye Moskowitz, MD PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.12231,
                        "lon": -80.14338
                    }
                },
                {
                    "facility": "University of Florida Health Shands",
                    "status": "RECRUITING",
                    "city": "Gainesville",
                    "state": "Florida",
                    "zip": "32608",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Phuong Deleyrolle",
                            "role": "CONTACT",
                            "phone": "352-273-5529",
                            "email": "phuong.deleyrolle@neurosurgery.ufl.edu"
                        },
                        {
                            "name": "Justin Hilliard, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.65163,
                        "lon": -82.32483
                    }
                },
                {
                    "facility": "Baptist Health South Florida & Florida International University",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33176",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Margarita Mederos",
                            "role": "CONTACT",
                            "phone": "786-596-1845",
                            "email": "Margarita.mederos@BaptistHealth.net"
                        },
                        {
                            "name": "Michael W. McDermott, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Tampa General Hospital",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Carlos Rodriguez-Cosme",
                            "role": "CONTACT",
                            "phone": "813-259-0633",
                            "email": "crodriguezcosme@tgh.org"
                        },
                        {
                            "name": "Yarema Bezchlibnyk, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Weill Cornell Medicine",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "The Ohio State University -Wexner Medical Center",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "University of Texas Southwestern Medical Center",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75390",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "West Virginia University Rockefeller Neuroscience Center",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Morgantown",
                    "state": "West Virginia",
                    "zip": "26506",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.62953,
                        "lon": -79.9559
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "34815790",
                    "type": "DERIVED",
                    "citation": "Mathew AS, Gorick CM, Price RJ. Multiple regression analysis of a comprehensive transcriptomic data assembly elucidates mechanically- and biochemically-driven responses to focused ultrasound blood-brain barrier disruption. Theranostics. 2021 Oct 11;11(20):9847-9858. doi: 10.7150/thno.65064. eCollection 2021."
                },
                {
                    "pmid": "33399511",
                    "type": "DERIVED",
                    "citation": "Mehta RI, Carpenter JS, Mehta RI, Haut MW, Ranjan M, Najib U, Lockman P, Wang P, D'haese PF, Rezai AR. Blood-Brain Barrier Opening with MRI-guided Focused Ultrasound Elicits Meningeal Venous Permeability in Humans with Early Alzheimer Disease. Radiology. 2021 Mar;298(3):654-662. doi: 10.1148/radiol.2021200643. Epub 2021 Jan 5."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000544",
                    "term": "Alzheimer Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003704",
                    "term": "Dementia"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000024801",
                    "term": "Tauopathies"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000019965",
                    "term": "Neurocognitive Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3885",
                    "name": "Alzheimer Disease",
                    "asFound": "Alzheimer's Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M6904",
                    "name": "Dementia",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23002",
                    "name": "Tauopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M21836",
                    "name": "Neurocognitive Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T2192",
                    "name": "Familial Alzheimer Disease",
                    "asFound": "Alzheimer's Disease",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}